Posted at 23 Jan, 17:36h in Press Release by adialpharma 0 Comments 0 Likes Share Adial Pharmaceuticals Closes Acquisition of Purnovate
Posted at 23 Jan, 17:35h in Press Release by adialpharma 0 Comments 0 Likes Share Adial Pharmaceuticals to Present at 23rd Annual ICR Conference
Posted at 11 Jan, 17:34h in Press Release by adialpharma 0 Comments 0 Likes Share Adial Pharmaceuticals Receives Notice of Allowance for Third U.S. Patent Covering AD04 for the Treatment for Opioid Use Disorder
Posted at 29 Sep, 13:56h in Press Release by adialpharma 0 Comments 2 Likes Share Adial Pharmaceuticals Announces COVID-19 Point-of-Care Antibody Test Granted First Ever FDA Emergency Use Authorization for Use with Fingerstick Blood Samples
Posted at 25 Sep, 13:54h in Press Release by adialpharma 0 Comments 0 Likes Share Adial Pharmaceuticals Files for Expedited Review of AD04 with the FDA
Posted at 22 Sep, 13:53h in Press Release by adialpharma 0 Comments 0 Likes Share Adial Pharmaceuticals and iRemedy Partner to Sell COVID-19 Antibody Test Kits to U.S. Medical Providers and Commence Sales
Posted at 06 Aug, 13:47h in Press Release by adialpharma 0 Comments 0 Likes Share Adial Pharmaceuticals Announces Third-Party Sales and Distribution Agreement with Brik for Rapid Result COVID-19 Antibody Test Kits
Posted at 30 Jul, 14:52h in Press Release by adialpharma 0 Comments 0 Likes Share Adial Pharmaceuticals Schedules Business and Clinical Update Conference Call
Posted at 22 Jul, 14:15h in Press Release, Uncategorized by adialpharma 0 Comments 0 Likes Share Adial Pharmaceuticals Receives European Medicines Agency (EMA) Agreement on the Pediatric Investigation Plan (PIP) for AD04 in Alcohol Use Disorder
Posted at 06 Jul, 12:24h in Press Release by adialpharma 0 Comments 0 Likes Share Adial Pharmaceuticals Announces Approval to Commence Landmark ONWARD(TM) Pivotal Phase 3 Trial in Sweden and Estonia
